Rchr
J-GLOBAL ID:202001013498486321   Update date: May. 05, 2021

Kai Masayuki

カイ マサユキ | Kai Masayuki
Affiliation and department:
Job title: Senior Manager
Papers (10):
  • Yuta Izumi, Masashi Kanayama, Zhongchuzi Shen, Masayuki Kai, Shunsuke Kawamura, Megumi Akiyama, Masahide Yamamoto, Toshikage Nagao, Keigo Okada, Norihiko Kawamata, et al. An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy. Frontiers in immunology. 2021. 12. 618081-618081
  • Yoshiyuki Kiyasu, Kenji Kawada, Hideyo Hirai, Ryotaro Ogawa, Keita Hanada, Hideyuki Masui, Gen Nishikawa, Takamasa Yamamoto, Rei Mizuno, Yoshiro Itatani, et al. Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice. Cancer letters. 2020. 487. 53-62
  • Ved P Sharma, Robert Eddy, David Entenberg, Masayuki Kai, Frank B Gertler, John Condeelis. Tks5 and SHIP2 regulate invadopodium maturation, but not initiation, in breast carcinoma cells. Current biology : CB. 2013. 23. 21. 2079-89
  • Masayuki Kai, Tetsuya Hagiwara, Chie Emuta, Yukiko Chisaka, Kumi Tsuruhata, Chisato Endo, Yoshimasa Inagaki, Hiroshi Miyazaki, Shiro Kataoka. In vivo efficacy of anti-MPL agonist antibody in promoting primary human hematopoietic cells. Blood. 2009. 113. 10. 2213-6
  • Masayuki Kai, Kazuhiro Motoki, Hideaki Yoshida, Chie Emuta, Yukiko Chisaka, Kumi Tsuruhata, Chisato Endo, Mari Muto, Munetake Shimabe, Uichi Nishiyama, et al. Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor. Nature biotechnology. 2008. 26. 2. 209-11
more...
MISC (4):
  • 泉 湧太, 金山 剛士, 秋山 めぐみ, 甲斐 正之, 沈 鐘楚子, 川又 紀彦, 樗木 俊聡. 単球性白血病の新規治療戦略としての単球系制限抗原の標的化(Targeting monocyte lineage-restricted antigen as a novel therapeutic strategy for monocytic leukemia). 日本病理学会会誌. 2020. 109. 1. 304-304
  • In vivo efficacy of anti-MPL agonist antibody for human hematopoietic cells. 2009. 59. 1. 73-77
  • Anti-thrombopoietin receptor whole-IgG agonist antibodies improved by domain-subclass conversion. Bio industry. 2008. 25. 7. 83-91
  • Masayuki Kai, Kazuhiro Motoki, Hideaki Yoshida, Kumi Tsuruhata, Chisato Endo, Mari Muto, Chie Emuta, Yukiko Chisaka, Munetake Shimabe, Hiroshi Miyazaki, et al. Domain subclass conversion improved activity of anti-Mpl agonist antibodies in the form of whole IgG. BLOOD. 2006. 108. 11. 336A-337A
Books (1):
  • 機能性DDSキャリアの製剤設計
    シーエムシー出版 2008 ISBN:9784781300528
Lectures and oral presentations  (1):
  • Anti-thrombopoietin receptor agonist antibodies improved by domain-sublcass conversion
    (The 14th international Conference on Human Antibodies & Hybridomas 2008)
Professional career (1):
  • Ph.D. (Tokyo Institute of Technology)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page